152074-07-2

Basic information

• Product Name: 2-BROMO-1-(2-ETHOXY-PHENYL)-ETHANONE
• Synonyms: 2-BROMO-1-(2-ETHOXY-PHENYL)-ETHANONE
• CAS NO: 152074-07-2
• Molecular Formula: C₁₀H₁₁BrO₂
• Molecular Weight: 243.1
• Mol File: 152074-07-2.mol
• Article Data: 3

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 2-BROMO-1-(2-ETHOXY-PHENYL)-ETHANONE(CAS DataBase Reference)
• NIST Chemistry Reference: 2-BROMO-1-(2-ETHOXY-PHENYL)-ETHANONE(152074-07-2)
• EPA Substance Registry System: 2-BROMO-1-(2-ETHOXY-PHENYL)-ETHANONE(152074-07-2)

Safety Data

• Hazardous Substances Data: 152074-07-2(Hazardous Substances Data)

Usage

Description

2-BROMO-1-(2-ETHOXY-PHENYL)-ETHANONE is an organic compound with the chemical structure of a bromo-ketone attached to an ethoxy-phenyl group. It is a versatile intermediate in the synthesis of various organic compounds and has potential applications in the pharmaceutical and chemical industries.

Uses

Used in Pharmaceutical Industry:
2-BROMO-1-(2-ETHOXY-PHENYL)-ETHANONE is used as a reagent for the preparation of aroylfurans and aroylthiophenes, which are compounds with potential therapeutic applications. These compounds are particularly effective in the treatment of neoplastic (cancerous) and autoimmune diseases, as they can modulate various biological pathways involved in these conditions.
Used in Chemical Industry:
In the chemical industry, 2-BROMO-1-(2-ETHOXY-PHENYL)-ETHANONE serves as an important building block for the synthesis of a wide range of organic compounds. Its unique structure allows for further functionalization and modification, making it a valuable asset in the development of new materials and chemicals with various applications.

Upstream product

• 2142-67-8 1-(2-ethoxyphenyl)ethanone 
• 118-93-4 o-hydroxyacetophenone 

Downstream Products

• 129486-35-7 4-(2-ethoxyphenyl)-2-<<4(5)-methyl-5(4)-imidazolyl>methyl>thiazole 

Relevant articles and documents

Discovery of novel potent GPR40 agonists containing imidazo[1,2-a]pyridine core as antidiabetic agents

Free fatty acid receptor 1 (FFA1 or GPR40) has been studied for many years as a target for the treatment of type 2 diabetes mellitus. In order to increase potency and reduce hepatotoxicity, a series of novel compounds containing imidazo[1,2-a]pyridine sca

Process for producing optically active carbinols

The present invention relates to a process for producing optically active halomethyl phenyl carbinols of the formula (1), comprising reducing halomethyl phenyl ketones of the formula (2) using an asymmetric reducing agent obtained from boranes and optically active α-phenyl-substituted-β-amino alcohols of the formula (3) or optically active α-non-substituted-β-amino alcohols of the formula (4). The present invention further relates to a process for producing optically active carbinols, comprising reacting a prochiral keytone with an asymmetric reducing agent obtained from optically active β-amino alcohols of the formula (5), a metal boron hydride and Lewis acid or lower dialkyl sulfuric acid. All of the formulas (1) to (5) are the same as shown in the specification.